rHEALTH Technology Featured in Publication for Cardiovascular Medicine

The rHEALTH® Sensor was recently highlighted in the Journal of Personalized Medicine, recognizing its growing impact in the evolution of next-generation cardiovascular diagnostics. The publication, led by Dr. Patrick Gladding, explores transformative “theranostic” technologies—those that combine both therapy and diagnostics—to enable earlier intervention, higher accuracy, and individualized patient care.

Healthcare systems worldwide are facing rising costs and diminishing returns, even as medical technology advances. Traditional models of care are no longer sustainable, particularly as chronic diseases such as cardiovascular illness and diabetes emerge as global challenges.

Personalized medicine offers a path forward by tailoring diagnostics and treatment to the individual rather than the population average. To fully realize this potential, large-scale interdisciplinary collaboration is essential. The article outlines a vision for open-access, advanced analytics integrating imaging, ECG data, and genomics to create a new standard of cardiac diagnostics—one that delivers precision, accessibility, and cost-effectiveness.